Skip to main content

Table 7 Symptom scales in maintenance therapy arms 1–3, and arms 2+3 versus control arm 5

From: A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study

Characteristic Arm 1
(n = 46)
Arm 2
(n = 76)
Arm 3
(n = 42)
Arms 2 + 3
(n = 118)
Arm 5
(n = 80)
At screening
 MS ± SD 19.68 ± 8.52 19.19 ± 8.90 18.19 ± 7.74 18.84 ± 8.49 19.71 ± 8.94
p* 0.9868 0.7207 0.3619 0.4953  
After combined treatment
 MS ± SD 31.39 ± 8.20 31.25 ± 7.77 31.66 ± 5.57 31.39 ± 7.05 31.25 ± 6.58
p* 0.9135 0.9999 0.7376 0.8870  
At the end of the study
 MS ± SD 34.59 ± 21.53 29.28 ± 20.33 30.01 ± 23.19 29.57 ± 21.34 34.83 ± 19.21
p* 0.9644 0.2494 0.3970 0.2588  
  1. MS mean score, SD standard deviation
  2. *Student’s test was applied to determine the differences between arms 1–3 vs arm 5 and arms 2+3 vs arm 5